Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 1, 2007
Diabetes Care 31:41-43, 2008
DOI: 10.2337/dc07-1711
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1711v1
31/1/41    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, W. L.
Right arrow Articles by Coleman, C. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, W. L.
Right arrow Articles by Coleman, C. I.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition/Psychosocial Research
Original Research

Effect of Cinnamon on Glucose Control and Lipid Parameters

William L. Baker, PHARMD, BCPS1,2, Gabriela Gutierrez-Williams, PHARMD2, C. Michael White, PHARMD, FCP, FCCP1,2, Jeffrey Kluger, MD3 and Craig I. Coleman, PHARMD1,2

1 Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs, Connecticut
2 Department of Drug Information, Hartford Hospital, Hartford, Connecticut
3 Department of Cardiology, Hartford Hospital, Hartford, Connecticut

Address correspondence and reprint requests to Craig I. Coleman, Pharm D, Assistant Professor of Pharmacy Practice, University of Connecticut, Hartford Hospital, 80 Seymour St., Hartford, CT 06102-5037. E-mail: ccolema{at}harthosp.org

OBJECTIVE—To perform a meta-analysis of randomized controlled trials of cinnamon to better characterize its impact on glucose and plasma lipids.

RESEARCH DESIGN AND METHODS—A systematic literature search through July 2007 was conducted to identify randomized placebo-controlled trials of cinnamon that reported data on A1C, fasting blood glucose (FBG), or lipid parameters. The mean change in each study end point from baseline was treated as a continuous variable, and the weighted mean difference was calculated as the difference between the mean value in the treatment and control groups. A random-effects model was used.

RESULTS—Five prospective randomized controlled trials (n = 282) were identified. Upon meta-analysis, the use of cinnamon did not significantly alter A1C, FBG, or lipid parameters. Subgroup and sensitivity analyses did not significantly change the results.

CONCLUSIONS—Cinnamon does not appear to improve A1C, FBG, or lipid parameters in patients with type 1 or type 2 diabetes.

Abbreviations: FBG, fasting blood glucose


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.